Bisoprolol: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 8: | Line 8: | ||
==Overview== | ==Overview== | ||
'''Bisoprolol''' is a drug belonging to the group of [[beta blocker]]s, a class of drugs used primarily in [[cardiovascular disease]]s. More specifically, it is a selective type β1 [[adrenergic receptor]] blocker <ref>[http://www.fass.se/LIF/produktfakta/artikel_produkt.jsp?NplID=20040326000029&DocTypeID=7&UserTypeID=2 FASS (Swedish official drug catalog) (labeling as "Selektiv beta1-blockerare" = selective beta1-blocker)]</ref>. | '''Bisoprolol''' is a drug belonging to the group of [[beta blocker]]s, a class of drugs used primarily in [[cardiovascular disease]]s. More specifically, it is a selective type β1 [[adrenergic receptor]] blocker <ref>[http://www.fass.se/LIF/produktfakta/artikel_produkt.jsp?NplID=20040326000029&DocTypeID=7&UserTypeID=2 FASS (Swedish official drug catalog) (labeling as "Selektiv beta1-blockerare" = selective beta1-blocker)]</ref>. | ||
==Category== | ==Category== | ||
Beta blockers | |||
==FDA Package Insert== | ==FDA Package Insert== | ||
Revision as of 03:42, 10 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
For patient information about Bisoprolol, click here
Synonyms / Brand Names: ZEBETA®
Overview
Bisoprolol is a drug belonging to the group of beta blockers, a class of drugs used primarily in cardiovascular diseases. More specifically, it is a selective type β1 adrenergic receptor blocker [1].
Category
Beta blockers
FDA Package Insert
| Indications and Usage | Dosage and Administration | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
The mechanism of action of its antihypertensive effects has not been completely established. Factors which may be involved include:
- Decreased cardiac output,
- Inhibition of renin release by the kidneys,
- Diminution of tonic sympathetic outflow from the vasomotor centers in the brain.